Different desensitization mechanisms of two alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta
- PMID: 1980076
- PMCID: PMC1368111
- DOI: 10.1111/j.1365-2125.1990.tb05481.x
Different desensitization mechanisms of two alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta
Abstract
Using alpha 1-adrenoceptor selective antagonists chlorethylclonidine (CEC) and WB4101, both functional and radioligand binding studies showed that rabbit aorta contains at least two pharmacologically distinct alpha 1-adrenoceptor subtypes of approximately 10% alpha 1a and 90% alpha 1b receptors, and that each receptor subtype has a distinct role in the alpha 1-adrenoceptor-mediated vasoconstrictive response through different biochemical mechanisms for increasing intracellular Ca2+; alpha 1a receptors cause tonic response predominantly dependent on the influx of extracellular Ca2+, while alpha 1b receptors stimulate phosphoinositides (PI) hydrolysis/intracellular Ca2+ mobilization and cause phasic response mainly independent of extracellular Ca2+. Incubation of rabbit aorta with 10 microM noradrenaline (NA) for 2 h resulted in a reduction in the phasic response and PI hydrolysis to NA with no change in the tonic response. Similar to the NA incubation, the protein kinase C stimulator PMA (1 microM) selectively attenuated alpha 1b-receptor mediated PI hydrolysis and phasic contraction but had little effect on alpha 1a-receptor-mediated tonic response. The protein kinase C inhibitor H-7 (10 microM) blocked these inhibitory effects of PMA. Treatment with H-7 (10 microM) prevented the NA-induced alpha 1b receptor desensitization in inositol monophosphate (IP) formation and phasic response. The results suggest that activation of C kinase may be involved in the development of selective desensitization of alpha 1b receptors by a short-time in vitro incubation of NA.
Similar articles
-
Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.Mol Pharmacol. 1990 Nov;38(5):725-36. Mol Pharmacol. 1990. PMID: 1978244
-
Pharmacological characterization of two distinct alpha 1-adrenoceptor subtypes in rabbit thoracic aorta.Br J Pharmacol. 1993 Apr;108(4):1071-6. doi: 10.1111/j.1476-5381.1993.tb13507.x. Br J Pharmacol. 1993. PMID: 8097950 Free PMC article.
-
Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx.Mol Pharmacol. 1989 Jul;36(1):166-76. Mol Pharmacol. 1989. PMID: 2546049
-
The alpha-adrenoceptor-mediated actions of chloroethylclonidine.Gen Pharmacol. 1997 Feb;28(2):197-201. doi: 10.1016/s0306-3623(96)00187-5. Gen Pharmacol. 1997. PMID: 9013194 Review.
-
Cardiac alpha(1)-adrenoceptors that regulate contractile function: subtypes and subcellular signal transduction mechanisms.Neurochem Res. 1996 Feb;21(2):217-29. doi: 10.1007/BF02529138. Neurochem Res. 1996. PMID: 9182246 Review.
Cited by
-
Participation of hepatic α/β-adrenoceptors and AT1 receptors in glucose release and portal hypertensive response induced by adrenaline or angiotensin II.Braz J Med Biol Res. 2018 Nov 14;51(12):e7526. doi: 10.1590/1414-431X20187526. Braz J Med Biol Res. 2018. PMID: 30462770 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous